Ginkgo Bioworks Holdings Inc
NYSE:DNA
Ginkgo Bioworks Holdings Inc
NYSE:DNA
Price:
0.7661 USD
-4.9%
Market Closed
Updated:
May 20, 2024
EV/S
Enterprise Value to Sales
Enterprise Value to Sales
3.5
Current
6.5
Median
1.6
Industry
Lower
than median
Higher
than industry value
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
EV/S
=3.5
Enterprise Value
/
725.5m
Revenue
208.7m
All Countries
| Market Cap | EV/S | ||||
|---|---|---|---|---|---|
| US |
|
Ginkgo Bioworks Holdings Inc
NYSE:DNA
|
1.6B USD | 3.5 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
78.6B USD | 3.8 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
12.1T JPY | 4.3 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
67.1B USD | 4.8 | |
| CH |
|
Sika AG
SIX:SIKA
|
45.2B CHF | 4.4 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
38.6B CHF | 6.1 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
282B CNY | 2.1 | |
| US |
|
Dupont De Nemours Inc
NYSE:DD
|
33.4B USD | 3.3 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.7T INR | 7.5 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
31.5B USD | 2 | |
| CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
28.8B EUR | 2.8 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/S
3.2
2-Years Forward
EV/S
2.3
3-Years Forward
EV/S
1.7
You don't have any saved screeners yet
